SCHEMBL6103251

SCHEMBL6103251

CC1(C)CCc2nc(-c3nc(-c4ccccc4)c(O)n3-c3ccccc3)ccc2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.46
TSHR P16473 1/20 0.32
LMNA P02545 3/20 0.32
RAB9A P51151 2/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 4/20 0.31
ALDH1A1 P00352 3/20 0.31
HPGD P15428 3/20 0.31
HSD17B10 Q99714 3/20 0.31
GAA P10253 2/20 0.31
GLA P06280 1/20 0.31
AKT1 P31749 3/20 0.31
MEN1 O00255 5/20 0.31
KMT2A Q03164 5/20 0.31
NPC1 O15118 1/20 0.30
MAPK1 P28482 1/20 0.30
CYP3A4 P08684 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4679352 0.88 GRM5 (0.46) GRM5TSHRBCHEACHEALDH1A1
SCHEMBL4684508 0.82 ALDH1A1 (0.42) GRM5TSHRLMNASMN1; SMN2HTT
SCHEMBL6103711 0.82 GRM5 (0.41) GRM5TSHRACHEHSD17B10GAA
SCHEMBL4739381 0.81 CYP2C19 (0.46) LMNARAB9ASMN1; SMN2HTTKDM4E
SCHEMBL4683600 0.81 GRM5 (0.40) GRM5RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4680738 0.80 GRM5 (0.39) GRM5KDM4EALDH1A1AKT1MEN1
SCHEMBL13706957 0.79 GRM5 (0.60) GRM5TSHRLMNARAB9ASMN1; SMN2
SCHEMBL4680787 0.79 GRM5 (0.47) GRM5LMNARAB9ASMN1; SMN2HTT
Hydrochloric Acid SCHEMBL4429413 0.78 GRM5 (0.59) GRM5TSHRLMNARAB9ASMN1; SMN2
SCHEMBL4679467 0.78 GRM5 (0.47) GRM5RAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US claimed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors GRM1, GRM5, GRM2 GRM5 2/4885TSHR 740/4885LMNA 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.